BSE filing, NSE: GUJALKALI. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Alkalies & Chemicals Ltd: key numbers
- Share price
- ₹549.05
- Market cap
- ₹4,032 Cr
- Revenue (annual)
- ₹4,358 Cr
- Net profit (annual)
- ₹-2.41 Cr
- P/E (TTM)
- 60.8×Sector 34.1×
- Promoter holding
- 47.28%+0.00% QoQ
- FII holding
- 3.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Alkalies & Chemicals Ltd
All →Gujarat Alkalies & Chemicals Board Meeting Date
GACL notified a board meeting on 5 November 2026 to consider Q2 and H1 FY27 provisional results. The trading window will remain closed until 7 November 2026.
Gujarat Alkalies & Chemicals Capacity Expansion
GACL conducted the ground-breaking ceremony of its 33,870 TPA food-grade phosphoric acid plant PPA-II at Dahej. The facility marks the start of construction for capacity expansion.
- phosphoric acid production capacity
- 33870 TPA
Gujarat Alkalies & Chemicals Other Announcement
Gujarat Alkalies and Chemicals Limited has published newspaper advertisements regarding a special window for the transfer and dematerialization of physical securities as per SEBI regulations.
Gujarat Alkalies & Chemicals Other Announcement
Gujarat Alkalies and Chemicals Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended 30 September 2026.
Gujarat Alkalies & Chemicals Annual General Meeting
Gujarat Alkalies and Chemicals Limited conducted its 53rd Annual General Meeting on September 25, 2026. Members considered dividend declaration and approval of material related party transactions.
Gujarat Alkalies & Chemicals Business Update
Gujarat Alkalies and Chemicals Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and operational metrics.
Other board meeting date announcements
All →Valiant Communications Board Meeting Date
Valiant Communications intimated that its Board will meet on 05-11-2026, inter alia to consider the Q1 FY27 unaudited results. The trading window stays closed until 48 hours after the results are announced.
Hannah Joseph Hospital Board Meeting Date
Hannah Joseph Hospital Ltd intimated a Board meeting on 05/11/2026 to approve H1 FY27 unaudited results. The trading window has been closed pending that announcement.
Kinetic Trust Board Meeting Date
Kinetic Trust Ltd intimated a Board meeting on 04/11/2026. The agenda includes approval of quarterly financial statements.
Lake Shore Realty Board Meeting Date
Lake Shore Realty Ltd has scheduled a board meeting on 02 Nov 2026 to approve unaudited standalone financial results for Q2 H1 FY27. No other agenda items specified beyond routine matters.
GTV Engineering Board Meeting Date
GTV Engineering scheduled a Board Meeting for 5 November 2026 to approve unaudited Q2 and half-year financial results. No new information is disclosed beyond the meeting notice.
Elixir Capital Board Meeting Date
Elixir Capital Ltd notified BSE that its Board will meet on 6 Nov 2026 to consider Q2/H1FY27 results. No financial figures or decisions are reported yet.